Clinical Trial Update: Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial examines maintenance therapy with decitabine and venetoclax after allogeneic stem cell transplant. It is a Phase 1/2 study in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myeloid Malignancy

Drugs mentioned

• Dacogen (decitabine)
• Venclexta (venetoclax)

Snippet

Sponsor: Benjamin Tomlinson | Conditions: Myeloid Malignancy, Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: RECRUITING